Goldman Sachs Group Inc Oric Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 322,625 shares of ORIC stock, worth $2.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322,625

Previous 278,810 15.72%

Holding current value

$2.74 Million

Previous $1.97 Million 67.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.52 - $11.9 $329,488 - $521,398	43,815 Added 15.72%	322,625 $3.31 Million
Q2 2024 Aug 13, 2024	BUY	$6.63 - $12.93 $723,545 - $1.41 Million	109,132 Added 64.32%	278,810 $1.97 Million
Q1 2024 May 15, 2024	BUY	$8.04 - $16.03 $955,875 - $1.91 Million	118,890 Added 234.09%	169,678 $2.33 Million
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $14,239 - $24,819	2,632 Added 5.47%	50,788 $467,000
Q3 2023 May 14, 2024	SELL	$6.05 - $9.28 $15,923 - $24,424	-2,632 Reduced 5.18%	48,156 $291,000
Q3 2023 Nov 14, 2023	SELL	$6.05 - $9.28 $48,484 - $74,369	-8,014 Reduced 14.27%	48,156 $291,000
Q2 2023 May 14, 2024	SELL	$4.95 - $8.4 $188,837 - $320,451	-38,149 Reduced 40.45%	56,170 $435,000
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $188,837 - $320,451	-38,149 Reduced 40.45%	56,170 $435,000
Q1 2023 May 14, 2024	BUY	$4.26 - $6.75 $284,406 - $450,643	66,762 Added 242.27%	94,319 $537,000
Q1 2023 May 11, 2023	BUY	$4.26 - $6.75 $401,798 - $636,653	94,319 New	94,319 $537,000
Q3 2022 May 14, 2024	SELL	$3.15 - $5.24 $109,714 - $182,509	-34,830 Reduced 55.83%	27,557 $88,000
Q3 2022 Nov 10, 2022	SELL	$3.15 - $5.24 $109,714 - $182,509	-34,830 Reduced 55.83%	27,557 $0
Q2 2022 May 14, 2024	BUY	$2.7 - $7.07 $31,317 - $82,004	11,599 Added 22.84%	62,387 $280,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $5,618 - $14,712	2,081 Added 3.45%	62,387 $280,000
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $74,415 - $263,895	16,391 Added 37.32%	60,306 $322,000
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $41,962 - $70,928	3,494 Added 8.64%	43,915 $645,000
Q3 2021 Nov 10, 2021	BUY	$15.9 - $25.22 $642,693 - $1.02 Million	40,421 New	40,421 $845,000

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Oric Pharmaceuticals, Inc. Transaction History